Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: Correlation with in-situ zymography

Atherosclerosis

Volumn 160, Issue 2, 2002, Pages 325-337

  Faia, Kerrie L ^a   Davis, Wendell P ^a   Marone, Adele J ^a   Foxall, Thomas L ^a  

^a UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

Atherosclerosis; In situ zymography; Matrix metalloproteinases; Syrian Golden hamster; Tissue inhibitors of matrix metalloproteinases; Vascular remodeling

Indexed keywords

1,10 PHENANTHROLINE; CASEIN; GELATIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CATALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYRIAN HAMSTER; TISSUE DISTRIBUTION; ZYMOGRAPHY;

ANIMALS; AORTA; AORTIC DISEASES; ARTERIOSCLEROSIS; CRICETINAE; IMMUNOHISTOCHEMISTRY; LIPIDS; MALE; MATRIX METALLOPROTEINASES; MESOCRICETUS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0036178388     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00590-1     Document Type: Article

References (35)

1. Macrophages and atherosclerotic plaque stability
2. The interface of atherosclerosis and thrombosis: Basic mechanisms
3. Activation of matrix metalloproteinases in the failing human heart
4. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases
5. 72-kDa Gelatinase (Gelatinase A); structure activation, regulation and substrate specificity
6. Transcriptional control of matrix metalloproteinases and their tissue inhibitors of matrix metalloproteinases
7. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
8. Matrix metalloproteinases and cardiovascular disease
9. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
10. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
11. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques
12. Doxazosin and cholestryamine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters
13. Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpus lutea and their variation during the estrous cycle
14. Collagenase, gelatinase, and proteoglycanase messenger ribonucleic acid expression and activity during luteal development, maintenance, and regression in the pseudopregnant rat ovary
15. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue
16. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis
17. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts
18. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases
19. Temporal and topographic matrix metalloproteinase expression after vascular injury in mice
20. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity
21. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein
22. TIMP-4 is regulated by vascular injury in rats
23. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
24. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery
25. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
26. The unstable atheroma
27. Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm
28. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinses -1, -2 in lung cancer - TIMP-1 as a prognostic marker
29. Florogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin
30. Endothelial-leukocyte adhesion molecules in human disease
31. Matrix metalloproteinase inhibitors
32. Atheroclerosis - An inflammatory disease
33. Reactive oxygen species produced by macrphage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro
34. Inactivation of tissue inhibitor of metallproteinase-1 by peroxynitrate
35. Oxidized low-density lipoprotein regulates matrix metalloproteinases-9 and its tissue inhibitor in human monocyte-derived macrophages